Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type b

Clinical trial NCT00808392 · COMPLETED

Trial details

NCT number: NCT00808392
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Haemophilus Influenzae Type b

Start date: 2008-11-01
Primary completion: 2009-02-01
Enrollment: 916

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.